Symbiotec Pharmalab Ltd

NSE: SYMBIOTEC · BSE: 544889 · Pharmaceuticals & Biotechnology · 7 announcements

Share price: ₹1,003.35
Market cap: ₹6,447 Cr
Revenue (annual): ₹869.1 Cr
Net profit (annual): ₹109.9 Cr
Promoter holding: 33.28%
FII holding: 21.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Share Pledge 1 Results Update 1 Financial Results 1 Capital Structure Change 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

22 Sep 2026 14:43 IST NSE

Earnings Call

Symbiotec Pharmalab Earnings Call Transcript: Key Takeaways

Symbiotec reported Q1 FY27 Revenue of ₹218 Cr, but underlying PAT remains soft due to heavy pre-operative expense drags from unmonetized new business segments.

Call: Guides 20% growth

Open call summary → Read the filing ↗

21 Sep 2026 19:47 IST BSE

Earnings Call

Symbiotec Pharmalab Investor Presentation: Key Takeaways

Symbiotec Pharmalab Q1FY27 results show steady 7% revenue growth in core API business, offset by high opex/depreciation from significant new capex in Injectables and CDMO services.

Open call summary → Read the filing ↗